[Cyclines and malaria]. / Cyclines et paludisme.
Med Trop (Mars)
; 67(1): 86-96, 2007 Feb.
Article
en Fr
| MEDLINE
| ID: mdl-17506281
ABSTRACT
The emergence and rapid spread of Plasmodium falciparum resistance to various antimalarials compounds is gradually reducing the clinician's options for treating malaria and for adapting prophylaxis to each traveler and destination. In this context doxycycline is an increasingly useful alternative except in individuals with contraindications, mainly children under the age of eight and pregnant women. Already used successfully in association with quinine for treatment of malaria in areas with multiresistance, doxycline has also proven to be effective and well tolerated for prophylaxis of malaria. No resistance to doxycycline has been observed to date. Most reported prophylactic failures have been related to poor compliance during the month following return from the endemic zone. The mechanisms of action of doxycycline on the parasite are still unclear. Identification of the molecular targets of doxycycline would open the way for the design of more active structural analogues with longer half-life.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Malaria Falciparum
Límite:
Animals
/
Humans
Idioma:
Fr
Revista:
Med Trop (Mars)
Asunto de la revista:
MEDICINA TROPICAL
Año:
2007
Tipo del documento:
Article
País de afiliación:
Francia